Skip to main content

Pharmacy

By Susan Morse | 05:23 pm | March 19, 2020
Optum Ventures is among companies investing $25 million, betting on the company's ability to show for which patients Humira doesn't work.
By Jeff Lagasse | 04:31 pm | March 17, 2020
The savings are due in part to strict price-reporting controls on pharmaceutical companies and the continuance of drug manufacturer rebates.
By Jeff Lagasse | 04:21 pm | March 04, 2020
Inflation-adjusted list prices increased by 159% from 2007 to 2018, while net prices increased 60%.
By Susan Morse | 05:17 pm | February 20, 2020
The formulary includes about 100 drugs, including insulin, and is expected to expand.
By Susan Morse | 03:31 pm | February 18, 2020
World Health Organization says it hopes to have a candidate vaccine in 16 weeks.
By Susan Morse | 12:09 pm | February 18, 2020
Millennials in particular want a discussion with their provider and will choose their physician based on the ability to discuss drug costs.
By Mark Klimek | 03:27 pm | February 06, 2020
Eleven drugs are potential blockbusters with an expected $1 billion in U.S. sales, according to the report.
By Susan Morse | 02:37 pm | February 06, 2020
Plan satisfaction will now have a greater effect on MA star ratings, as the Advance Notice proposes to double the value member satisfaction.
By Susan Morse | 04:56 pm | February 05, 2020
The president promised to protect Medicaid, yet his Administration's proposal to change the funding mechanism would cap funds, physician says.
By Jeff Lagasse | 04:05 pm | February 03, 2020
As commercial health plans and others fortify their strategy for preventive care, one opportunity is to leverage an existing retail footprint.